Omodenbamab: A Deep Dive into the 2241724-48-9 Monoclonal Antibody
Omodenbamab therapeutic agent, designated with the code 2241724-48-9, represents: is a novel monoclonal protein currently subject to investigation regarding its potential: possible therapeutic purposes, specifically targeting adcy2. Investigators are: have been exploring its mechanism: mode of op